Aluminium clofibrate
Chemical compound
- C10AB03 (WHO)
- Aluminium bis(2-(4-chlorophenoxy)-2-methylpropanoate) hydroxide
- 24818-79-9 N
- 6328223
- 11644433 Y
- 56203T2K2X
- D01208 Y
- DTXSID70905093
- Interactive image
- Clc2ccc(OC(C)(C)C(=O)O[Al](O)OC(=O)C(C)(C)Oc1ccc(Cl)cc1)cc2
InChI
- InChI=1S/2C10H11ClO3.Al.H2O/c2*1-10(2,9(12)13)14-8-5-3-7(11)4-6-8;;/h2*3-6H,1-2H3,(H,12,13);;1H2/q;;+3;/p-3 Y
- Key:USWVMPGQVYZHCA-UHFFFAOYSA-K Y
Aluminium clofibrate (or alfibrate) is a fibrate.
See also
References
- v
- t
- e
Cholesterol absorption inhibitors, NPC1L1 | |
---|---|
Bile acid sequestrants/resins (LDL) |
Statins (HMG-CoA reductase, LDL) | |
---|---|
Niacin and derivatives (HDL and LDL) | |
MTTP inhibitors (VLDL) | |
ATP citrate lyase inhibitors (LDL) | |
Thyromimetics (VLDL) |
PPAR agonists (LDL) |
| ||||
---|---|---|---|---|---|
CETP inhibitors (HDL) | |||||
PCSK9 inhibitors (LDL) | |||||
ANGPTL3 inhibitors (LDL/HDL) |
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e